Articles tagged "Elderly patients"

2017 American Transplant Congress
Single Kidney Transplantation from DCD Maastricht Category 3 Donors ≥ 60 Years: Is It Safe?
E. Favi,¹ C. Puliatti,² M. Ferraresso,¹ S. Iesari,³ R. Cacciola.²
¹Renal Transplant, Ospedale Maggiore Policlinico, Milan, Italy; ²Renal Transplantation, The Royal London Hospital, London, United Kingdom; ³Organ Transplant, Presidio Ospedaliero S. Salvatore, L'Aquila, Italy
Aim. Compared to DBD, DCD kidneys show higher rates of primary non function (PNF), DGF, rejection, and premature transplant (Tx) loss. Some authors have advised…
2017 American Transplant Congress
Use of Modified Geriatric Assessment in Evaluation of Older Adults for Kidney Transplant Suitability.
K. Campbell,¹ F. Enger, E. Patrick,² M. Saunders,³ M. Josephson,¹ Y. Becker.²
¹Medicine, University of Chicago, Chicago, IL; ²Kidney Transplant, University of Chicago, Chicago, IL; ³Hospital Medicine, University of Chicago, Chicago, IL
BackgroundThere is an increasing incidence and prevalence of older adults with ESRD. Per guideline recommendations, many of these patients are now being considered for kidney…
2017 American Transplant Congress
Induction Therapy in Low Risk Elderly Kidney Transplant Recipients: Donor Factors.
F. Al Ammary, M. DeMarco, Q. Huang, E. King, S. Bay, A. Muzaale, A. Wiseman, D. Segev.
Johns Hopkins, Baltimore; University of Colorado, Denver
It is not known whether depleting induction is needed in low-risk elderly kidney transplant (KT) recipients in whom concern for infectious and complications is higher…
2017 American Transplant Congress
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.
A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
¹Epidemiology, Johns Hopkins University, Baltimore, MD; ²Surgery, Johns Hopkins University, Baltimore, MD; ³Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD
INTRODUCTION. Few objective tests can be easily performed prior to kidney transplantation (KT) to effectively stratify patients by risk of post-KT mortality. The short physical…
2017 American Transplant Congress
Transplant Readiness Assessment Clinic: A New Approach to Kidney Waitlist Management in the KAS Era.
X. Cheng,¹ J. Lee,² Z. Tulu,² J. Tan.²
¹Div Nephrology, Stanford University, Palo Alto; ²Kidney Transplant Program, Stanford University, Palo Alto, CA
Kidney waitlist management has become increasingly complex in regions with long wait times. Increasing transplant options and the new Kidney Allocation System has added to…
2017 American Transplant Congress
Cross-sectional and Serial Evolution of Quality of Life in Elderly Kidney Donors.
S. Ake,¹ D. Berglund,² S. Jackson,³ A. Matas,² C. Gross,² H. Ibrahim.²
¹Saint Catherine University, St. Paul; ²U of MN, Mpls; ³M Health, Mpls
Little is known regarding long-term health-related quality of life (HRQOL) in elderly (those donating when ≥65 yrs) living kidney donors (LKDs). Using the SF-36, we…
2016 American Transplant Congress
Outcomes of Sequential and En Bloc Transplants in the Elderly: 10 Year Review of UNOS Data.
V. Whittaker,¹ R. Gruessner,¹ A. Vikram,² A. Gruessner.
¹Surgery, SUNY Upstate Medical University, Syracuse, NY; ²Medicine, SUNY Upstate Medical University, Syracuse, NY.
To evaluate the outcome of sequential and en bloc transplants in the elderly.Method: Retrospective review UNOS data 2004-2014 kidney transplant alone patients >65 years. Patient…
2016 American Transplant Congress
Hospitalizations, Survival, and Complications: 1-Year Outcomes for Elderly Lung Transplant Recipients.
N. Casciello, A. Fuentes, J. Krisl, N. Sinha, T. Kaleekal.
Houston Methodist Hospital, Houston, TX.
Purpose: In 2014, The International Society for Heart and Lung Transplantation published consensus guidelines listing age greater than 65 years as a relative contraindication to…
2016 American Transplant Congress
Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.
I. Yakubu,¹ B. Masters,¹ B. Ravichandran,¹ T. Sparkes,¹ M. Moss,¹ F. Rasetto,¹ S. Jonchhe,¹ B. Thomas,² N. Costa,² D. Leeser,² S. Bartlett,² A. Haririan.²
¹Pharmacy, University of Maryland Medical Center, Baltimore; ²University of Maryland Medical Center, Baltimore.
Background: In descriptive studies, alemtuzumab has been associated with an escalating risk of death and graft loss in elderly (≥65 years) kidney transplant recipients. However,…
2016 American Transplant Congress
Outcomes in Elderly Renal Transplant Recipients Using Thymoglobulin or Interleukin-2 Receptor Antagonist Induction.
N. Jasiak,¹ J. Thielke,¹ J. Chen,² N. Hilal,¹ S. Salah,¹ D. Wu,¹ E. Benedetti,² P. West-Thielke.^1,2
¹Pharmacy, University of Illinois, Chicago; ²Transplant Surgery, University of Illinois, Chicago.
Background: Approximately 20% of all renal transplants performed in the US in 2014 occurred in elderly patients. Elderly patients are known to be at higher…